Literature DB >> 23252972

A successful treatment with ustekinumab in a case of antilaminin-γ1 pemphigoid associated with psoriasis.

Y Majima, H Yagi, C Tateishi, S Groth, E Schmidt, D Zillikens, H Koga, T Hashimoto, Y Tokura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23252972     DOI： 10.1111/bjd.12163

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  9 in total

Review 1.  Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.

Authors:  Kyle T Amber; Dedee F Murrell; Enno Schmidt; Pascal Joly; Luca Borradori
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

Review 2.  The continuing evolution of targeted therapy for inflammatory skin disease.

Authors:  C Schlapbach; A A Navarini
Journal:  Semin Immunopathol       Date:  2015-09-30       Impact factor: 9.623

Review 3.  A Review of the Immunologic Pathways Involved in Bullous Pemphigoid and Novel Therapeutic Targets.

Authors:  Mohsen Afarideh; Robert Borucki; Victoria P Werth
Journal:  J Clin Med       Date:  2022-05-18       Impact factor: 4.964

4.  Bullous pemphigoid during ustekinumab therapy.

Authors:  Aurore Le Guern; Salim Alkeraye; Annie Vermersch-Langlin; Patrick Coupe; Marlène Vonarx
Journal:  JAAD Case Rep       Date:  2015-10-02

Review 5.  Interaction of Psoriasis and Bullous Diseases.

Authors:  Teruki Dainichi; Kenji Kabashima
Journal:  Front Med (Lausanne)       Date:  2018-08-08

6.  Anti-p200 Pemphigoid: A Systematic Review.

Authors:  Khalaf Kridin; A Razzaque Ahmed
Journal:  Front Immunol       Date:  2019-10-22       Impact factor: 7.561

7.  Coexistence of Anti-p200 Pemphigoid and Psoriasis: A Systematic Review.

Authors:  Ying-Han Xie; Si-Hang Wang; Si-Zhe Li; Ya-Gang Zuo
Journal:  Front Immunol       Date:  2022-03-04       Impact factor: 7.561

Review 8.  Alternative uses of ustekinumab for non-indicated dermatological conditions: a systematic review.

Authors:  Sahil Rawal; Sara Kianian; William Guo; Jocellie Marquez; Marissa Ayasse; Katherine A Siamas; Yoojin Lee; Joann Salvemini
Journal:  Arch Dermatol Res       Date:  2021-06-22       Impact factor: 3.017

9.  Erythrodermic psoriasis with bullous pemphigoid: combination treatment with methotrexate and compound glycyrrhizin.

Authors:  Xiaoqing Si; Lingzhi Ge; Hongyan Xin; Wang Cao; Xiaohui Sun; Wenfei Li
Journal:  Diagn Pathol       Date:  2014-05-29       Impact factor: 2.644
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.